Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

NCT02338232 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
32
Enrollment
OTHER
Sponsor class

Stopped Lack of Accrual

Conditions

Interventions

Sponsor

Hackensack Meridian Health